NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »           NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »          NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »
Research / Case Study / Case Study : Partnering with Patient Advocacy to Deliver Genetic Services and Accelerate Clinical Trial Recruitment

Case Study : Partnering with Patient Advocacy to Deliver Genetic Services and Accelerate Clinical Trial Recruitment

InformedDNA provides expert genetics services to foundations and patient advocacy organizations. We’ve successfully addressed the challenge that many foundations face in supporting patients through the genetic testing and screening process necessary to identify appropriate candidates for clinical trial eligibility. We also help patient foundations to effectively leverage their outreach capabilities to engage pharmaceutical companies while continuing to focus on the needs of the patient community.

In this case study with Foundation Fighting Blindness, the world’s leading private funder of retinal disease research, we share how our genetics experts addressed some key challenges faced by the Foundation:

  • Difficult to identify trial candidates
  • Scarity of genetic testing data
  • Limited access to genetic specialists

The program impacted care for greater than 30% of clinical trial participants.

Fill out the form below to download your FREE copy of our Case Study

Fill out the form below to download your FREE copy of our Case Study

Recent Posts

The Cancer Letter: Joint byline, ‘Is gastrectomy indicated?’

A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates. InformedDNA, FORCE: Facing Our Risk of Cancer Empowered, and No Stomach For Cancer, collaborate as patient advocates, educators, and experts to support individuals and families impacted by gastric cancer to help them navigate this complex genetic landscape. Subscribers to The Cancer Letter can login to read the full article.

Read More »

How can we help?

Reach out today to speak with a specialist and learn more about how our decades of experience and breadth of knowledge across all genetics subspecialties can work for your organization.
×